Triatomic Management LP Senti Biosciences, Inc. Transaction History

Triatomic Management LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$0.24 - $0.4 $70,809 - $118,016	-295,040 Reduced 95.01%	15,493 $4.28 Million
Q3 2023 Nov 03, 2023	BUY	$0.41 - $0.99 $4,100 - $9,900	10,000 Added 3.33%	310,533 $127,000
Q2 2023 Aug 14, 2023	BUY	$0.6 - $1.14 $53,790 - $102,200	89,650 Added 42.51%	300,533 $189,000
Q1 2023 May 03, 2023	BUY	$1.15 - $2.06 $68,089 - $121,968	59,208 Added 39.04%	210,883 $248,000
Q4 2022 Feb 13, 2023	BUY	$1.25 - $65.2 $119,026 - $6.21 Million	95,221 Added 168.67%	151,675 $213,000
Q3 2022 Nov 14, 2022	BUY	$1.33 - $21.7 $75,083 - $1.23 Million	56,454 New	56,454 $123,000

342K

Ticker SNTI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,757,100
Market Cap $96.3M
Description
Senti Biosciences, Inc. operates as a gene circuit company. The company develops cell and gene therapies engineered with gene circuits that are designed to reprogram cells with biological logic to sense inputs, compute decisions, and respond to respective cellular environments. Its synthetic biology platform utilizes off-the-shelf chimeric antig...

Get notified when there are updates to the investment portfolio of Triatomic Management LP, based on Form 13F filings with the SEC.

Stay updated on Triatomic Management LP with notifications on news.